Bathi operasional EBITDA: Sanara MedTech Inc. (SMTI)

Analyzing the EBITDA chart on GURU.Markets, we see that Sanara MedTech Inc. (SMTI) has stabilized at the 13.95 level. High barriers to entry are ensured by patents and strict FDA control. Sanara MedTech Inc. (SMTI) is developing a comprehensive suite of surgical solutions, integrating its materials into hospital protocols. The advantage of Sanara MedTech Inc. (SMTI) is based on the unique composition of CellerateRX, which accelerates tissue regeneration and minimizes infection risks.

Bathi sadurunge mbayar bunga, pajak, lan amortisasi: sanaramedtech.com (SMTI) kanggo 23.11.2025 - 12.11.2026

Sanara MedTech (SMTI) - rincian metrik lan laporan keuangan

- nilai saham lan prakiraan konsensus rega:

Bagan bursa Sanara MedTech, Inc.|SMTI - Bagan rega target

- indikator kapitalisasi bursa perusahaan:

Kapitalisasi pasar Sanara MedTech|SMTI - Nilai Perusahaan

- indikator nilai buku ekuitas:

Aset Bersih saben Saham Sanara MedTech|SMTI - Nilai Buku Perusahaan|Rasio Kapitalisasi marang Nilai Buku sanaramedtech.com|SMTI - Aset Agregat Perusahaan

- rincian struktur utang lan likuiditas bisnis:

Koefisien Total Utang marang Modal Sanara MedTech Inc.|SMTI - Utang jangka dawa marang modal|Utang jangka cendhak marang modal Sanara MedTech, Inc.|SMTI - Utang perusahaan|Rasio utang marang nilai buku Sanara MedTech|SMTI - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Sanara MedTech|Rasio jangkoan perantara sanaramedtech.com

- indikator profitabilitas perusahaan lan kelipatan valuasi:

SMTI - Bathi resik|Proyeksi bathi mangsa ngarep Sanara MedTech Inc.|SMTI - Koefisien rega marang bathi|Pangali mangsa ngarep rega marang bathi Sanara MedTech, Inc.|SMTI - Rasio rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Sanara MedTech|SMTI - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan Sanara MedTech|SMTI - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan sanaramedtech.com|SMTI - Wutah bathi resik saben saham ing taun iki|Proyeksi tambahing bathi saben saham ing taun ngarep Sanara MedTech Inc.

Analisis kabeh metrik perusahaan:Sanara MedTech Inc. - SMTI

Absolute operating profit in cash reflects the daily cash flow from the core activities of Sanara MedTech Inc. (SMTI) amid expensive liquidity, allowing for the real-time tracking of business efficiency between quarterly reports. An analysis of EBITDA history demonstrates how successfully the implementation of AI automation in biomaterial production optimizes costs and converts technological deployment into real financial results.

Karo sapa Sanara MedTech Inc. saingan